Civatech Oncology: Funding, Investors & Team (Aug 2026)
Civatech Oncology is a healthcare equipment company that creates devices made from polymers to combat cancer through localized radiation therapy with a low dose rate. The advantage of using polymers is their versatility in manufacturing various shapes and structures, allowing CivaTech to design and produce devices specifically tailored to different types of tumors. Their initial product, the CivaString, has received clearance from the FDA to treat all solid tumor types. Established in 2006, the company is headquartered in Durham, North Carolina, in the United States.
Civatech Oncology has raised $4.0M across 1 funding round on record, the most recent an undisclosed round of $4.0M announced in Aug 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Civatech Oncology Company Profile and Key Stats
Latest funding round on record: Aug 2023.
Civatech Oncology Funding Rounds
Civatech Oncology Founders and Leadership Team
No contact details are on record for this team yet.
Civatech Oncology Funding Compared to Other Biotechnology Startups
Civatech Oncology's latest round of $4.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Civatech Oncology in Biotechnology and Durham
Companies Similar to Civatech Oncology
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Civatech Oncology Funding FAQs
What does Civatech Oncology do?
Civatech Oncology is a healthcare equipment company that creates devices made from polymers to combat cancer through localized radiation therapy with a low dose rate. The advantage of using polymers is their versatility in manufacturing various shapes and structures, allowing CivaTech to design and produce devices specifically tailored to different types of tumors. Their initial product, the CivaString, has received clearance from the FDA to treat all solid tumor types. Established in 2006, the company is headquartered in Durham, North Carolina, in the United States.
How much funding has Civatech Oncology raised?
Civatech Oncology has raised $4.0M across 1 round on record. The most recent is an undisclosed round of $4.0M announced in Aug 2023.
When did Civatech Oncology last raise funding?
Civatech Oncology's most recent funding round on record is an undisclosed round of $4.0M, announced in Aug 2023.
Who founded Civatech Oncology?
FundedIQ lists Suzanne Troxler Babcock (Founder) at Civatech Oncology.
Where is Civatech Oncology headquartered?
Civatech Oncology is based in Durham, North Carolina, United States.
How many employees does Civatech Oncology have?
Civatech Oncology is in the 1-10 employee band.
How does Civatech Oncology's funding compare to other Biotechnology startups?
Civatech Oncology's latest round of $4.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Civatech Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Civatech Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.